Advertisement
TRLV vs YCBD
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is TRLV is a Buy and YCBD is a Buy.
TRLV in +7.00% Uptrend, growing for three consecutive days on October 21, 2026
Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where TRLV advanced for three days, in 188 of 233 cases, the price rose further within the following month. The odds of a continued upward trend are 81%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on October 26, 2026. You may want to consider a long position or call options on TRLV as a result. In 69 of 87 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 79%.
The Moving Average Convergence Divergence (MACD) for TRLV just turned positive on October 22, 2026. Looking at past instances where TRLV's MACD turned positive, the stock continued to rise in 28 of 35 cases over the following month. The odds of a continued upward trend are 80%.
Bearish Trend Analysis
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 41 of 49 cases where TRLV's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 84%.
TRLV moved below its 50-day moving average on October 08, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for TRLV crossed bearishly below the 50-day moving average on October 12, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 10 of 16 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 62%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where TRLV declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 85%.
The Aroon Indicator for TRLV entered a downward trend on October 26, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron Price Growth Rating for this company is 45 (best 1 - 100 worst), indicating steady price growth. TRLV’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 47 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.715) is normal, around the industry mean (8.413). P/E Ratio (-4.381) is within average values for comparable stocks, (-1.728). Projected Growth (PEG Ratio) (0.470) is also within normal values, averaging (2.152). Dividend Yield (0.000) settles around the average of (0.047) among similar stocks. P/S Ratio (1.947) is also within normal values, averaging (178.797).
The Tickeron PE Growth Rating for this company is 65 (best 1 - 100 worst), pointing to average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 98 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. TRLV’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 84, placing this stock worse than average.
YCBD's MACD Histogram just turned positive
The Moving Average Convergence Divergence (MACD) for YCBD turned positive on October 21, 2026. Looking at past instances where YCBD's MACD turned positive, the stock continued to rise in 37 of 38 cases over the following month. The odds of a continued upward trend are 90%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where YCBD's RSI Oscillator exited the oversold zone, 34 of 40 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 85%.
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 69 of 79 cases where YCBD's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 87%.
The Momentum Indicator moved above the 0 level on October 26, 2026. You may want to consider a long position or call options on YCBD as a result. In 85 of 109 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 78%.
YCBD may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Bearish Trend Analysis
Following a 3-day decline, the stock is projected to fall further. Considering past instances where YCBD declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.
The Aroon Indicator for YCBD entered a downward trend on October 22, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron Valuation Rating of 41 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.498) is normal, around the industry mean (8.413). P/E Ratio (1.586) is within average values for comparable stocks, (-1.728). Projected Growth (PEG Ratio) (0.040) is also within normal values, averaging (2.152). Dividend Yield (0.000) settles around the average of (0.047) among similar stocks. P/S Ratio (0.217) is also within normal values, averaging (178.797).
The Tickeron PE Growth Rating for this company is 69 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 88 (best 1 - 100 worst), indicating slightly worse than average price growth. YCBD’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 98 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. YCBD’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 84, placing this stock worse than average.
TRLV | YCBD | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 70 | 51 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 47 Fair valued | 41 Fair valued | |
PROFIT vs RISK RATING 1..100 | 100 | 100 | |
SMR RATING 1..100 | 98 | 98 | |
PRICE GROWTH RATING 1..100 | 45 | 88 | |
P/E GROWTH RATING 1..100 | 65 | 69 | |
SEASONALITY SCORE 1..100 | n/a | n/a |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
YCBD's Valuation (41) in the Other Consumer Services industry is in the same range as TRLV (47) in the null industry. This means that YCBD’s stock grew similarly to TRLV’s over the last 12 months.
YCBD's Profit vs Risk Rating (100) in the Other Consumer Services industry is in the same range as TRLV (100) in the null industry. This means that YCBD’s stock grew similarly to TRLV’s over the last 12 months.
YCBD's SMR Rating (98) in the Other Consumer Services industry is in the same range as TRLV (98) in the null industry. This means that YCBD’s stock grew similarly to TRLV’s over the last 12 months.
TRLV's Price Growth Rating (45) in the null industry is somewhat better than the same rating for YCBD (88) in the Other Consumer Services industry. This means that TRLV’s stock grew somewhat faster than YCBD’s over the last 12 months.
TRLV's P/E Growth Rating (65) in the null industry is in the same range as YCBD (69) in the Other Consumer Services industry. This means that TRLV’s stock grew similarly to YCBD’s over the last 12 months.
| TRLV | YCBD | |
|---|---|---|
| RSI ODDS (%) | N/A | 1 day ago 85% |
| Stochastic ODDS (%) | 1 day ago 84% | 1 day ago 87% |
| Momentum ODDS (%) | 1 day ago 79% | 1 day ago 78% |
| MACD ODDS (%) | 1 day ago 80% | 1 day ago 90% |
| TrendWeek ODDS (%) | 1 day ago 83% | 1 day ago 82% |
| TrendMonth ODDS (%) | 1 day ago 84% | 1 day ago 90% |
| Advances ODDS (%) | 6 days ago 81% | N/A |
| Declines ODDS (%) | 4 days ago 85% | 4 days ago 90% |
| BollingerBands ODDS (%) | N/A | 1 day ago 78% |
| Aroon ODDS (%) | 1 day ago 77% | 1 day ago 90% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
TRLV’s FA Score shows that 0 FA rating(s) are green while YCBD’s FA Score has 0 green FA rating(s).
- TRLV’s FA Score: 0 green, 5 red.
- YCBD’s FA Score: 0 green, 5 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
TRLV’s TA Score shows that 3 TA indicator(s) are bullish while YCBD’s TA Score has 5 bullish TA indicator(s).
- TRLV’s TA Score: 3 bullish, 5 bearish.
- YCBD’s TA Score: 5 bullish, 2 bearish.
Price Growth
TRLV (@Pharmaceuticals: Generic) experienced а +5.25% price change this week, while YCBD (@Pharmaceuticals: Generic) price change was +4.80% for the same time period.
The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was -3.57%. For the same industry, the average monthly price growth was -11.91%, and the average quarterly price growth was +7.55%.
Reported Earning Dates
TRLV is expected to report earnings on Nov 05, 2026.
YCBD is expected to report earnings on Dec 18, 2026.
Industries' Descriptions
@Pharmaceuticals: Generic (-3.57% weekly)A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.
Advertisement
TRLV and
Correlation & Price change
A.I.dvisor indicates that over the last year, TRLV has been closely correlated with CGC. These tickers have moved in lockstep 67% of the time. This A.I.-generated data suggests there is a high statistical probability that if TRLV jumps, then CGC could also see price increases.
| Ticker / NAME | Correlation To TRLV | 1D Price Change % | ||
|---|---|---|---|---|
| TRLV | 100% | +3.84% | ||
| CGC - TRLV | 67% Closely correlated | -1.14% | ||
| GLAS - TRLV | 65% Loosely correlated | N/A | ||
| TLRY - TRLV | 58% Loosely correlated | -3.20% | ||
| ACB - TRLV | 56% Loosely correlated | +0.52% | ||
| CRON - TRLV | 55% Loosely correlated | -1.19% | ||
More | ||||
YCBD and
Correlation & Price change
A.I.dvisor indicates that over the last year, YCBD has been loosely correlated with TLRY. These tickers have moved in lockstep 58% of the time. This A.I.-generated data suggests there is some statistical probability that if YCBD jumps, then TLRY could also see price increases.
| Ticker / NAME | Correlation To YCBD | 1D Price Change % | ||
|---|---|---|---|---|
| YCBD | 100% | +0.61% | ||
| TLRY - YCBD | 58% Loosely correlated | -3.20% | ||
| TRLV - YCBD | 48% Loosely correlated | +3.84% | ||
| GLAS - YCBD | 43% Loosely correlated | N/A | ||
| CRON - YCBD | 40% Loosely correlated | -1.19% | ||
| DERM - YCBD | 24% Poorly correlated | -1.00% | ||
More | ||||